Potential of Mesenchymal Stem Cells and Their Secretomes in Decreasing Inflammation Markers in Polycystic Ovary Syndrome Treatment: A Systematic Review


Abstract

Summary:

This paper reviews the potential of Mesenchymal Stem Cells (MSCs) and their secretomes in decreasing inflammation markers in Polycystic Ovary Syndrome (PCOS) treatment.
Categories

Categories

  • Reproductive health: The paper discusses the use of Mesenchymal Stem Cells (MSCs) and their secretomes in the treatment of Polycystic Ovary Syndrome (PCOS), a common endocrine disorder in women of reproductive age.
Authors

Author(s)

GD Prayitno, K Lestari, CR Sartika, T Djuwantono
Publication Date

Publication Year:

2022
Citations

Number of Citations:

5